White, P. Lewis
Alanio, Alexandre
Cruciani, Mario
Gorton, Rebecca
Millon, Laurence
Rickerts, Volker
Barnes, Rosemary A.
Donnelly, J. Peter
Loeffler, Juergen
Article History
First Online: 21 January 2020
Compliance with Ethical Standards
:
: P. Lewis White reports personal fees from F2G, Gilead, MSD and BOPA, received funding for travel and meeting attendance from Gilead, Launch Diagnostics, BOPA and Bruker Diagnostics and received research funding from Bruker Diagnostics. Dr. White received payment from F2G for providing diagnostic services outside the submitted work. Alexandre Alanio reports non-financial support from Astellas and personal fees from Gilead science outside the submitted work. In addition, Dr. Alanio has a patent on a means for diagnosing, predicting or monitoring Pneumocystis pneumonia issued. Laurence Millon reports support for travel to meetings from Gilead, personal fees from Gilead, support for travel to meetings from Pfizer, personal fees from Pfizer, and support for travel to meetings from MSD outside the submitted work. Rosemary Barnes being treasurer and Steering Committee member of the Fungal PCR Initiative. Joseph Peter Donnelly reports personal fees from F2G, Gilead and Pfizer outside the submitted work. Mario Cruciani, Rebecca Gorton, Volker Rickerts and Juergen Loeffler declare no conflicts of interest relevant to this manuscript.
: This article does not contain any studies with human or animal subjects performed by any of the authors.